German COVID-19 vaccine maker BioNTech, partner of US pharmaceutical group Pfizer, said on Monday it aims to produce two billion doses of its vaccine this year.
Visit our dedicated coronavirus site here for all the latest updates.
“We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated 6-dose label,” BioNTech said in a presentation.
Read more:
EU doubles coronavirus vaccine deal with Pfizer-BioNTech to 600 mln doses
Pfizer/BioNTech vaccine works against new COVID-19 strain, study shows
BioNTech says no data to support delayed COVID-19 vaccine booster shot
Also Read
-
EU doubles coronavirus vaccine deal with Pfizer-BioNTech to 600 mln doses
The European Union reached a deal with Pfizer and BioNTech for 300 million additional doses of their COVID-19 vaccine, doubling the amountof doses ... Coronavirus -
Coronavirus: Pfizer/BioNTech vaccine works against new COVID-19 strain, study shows
Pfizer Inc and BioNTech’s COVID-19 vaccine appeared to work against a key mutation in the highly transmissible new variants of the coronavirus ... Coronavirus -
Coronavirus: BioNTech says no data to support delayed COVID-19 vaccine booster shot
BioNTech and partner Pfizer warned on Monday that they had no evidence that their jointly developed vaccine will continue to protect against COVID-19 ... Coronavirus -
Coronavirus: Spain will administer two doses of BioNTech-Pfizer COVID-19 vaccine
Spain’s central health authority will continue to recommend administering two doses of the BioNTech-Pfizer vaccine in the period indicated by its ... Coronavirus -
Coronavirus: Pfizer, BioNTech offer vaccine to volunteers who got placebo
Pfizer Inc and its partner BioNTech Se plan to give volunteers who received a placebo in its COVID-19 vaccine trial an option to receive a first dose ... Coronavirus -
BioNTech to boost vaccine production, say can’t fully cover lack of other vaccines
BioNTech is working flat out with partner Pfizer to boost production of their COVID-19 vaccine, its founders said, warning there would be gaps in ... Coronavirus
